These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38744274)

  • 1. Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment.
    Hu WT; Kaluzova M; Dawson A; Sotelo V; Papas J; Lemenze A; Shu C; Jomartin M; Nayyar A; Hussain S
    Cell Rep Med; 2024 May; 5(5):101561. PubMed ID: 38744274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
    Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
    Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    Li TR; Lyu DY; Liu FQ;
    J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
    Schweitzer F; Goereci Y; Franke C; Silling S; Bösl F; Maier F; Heger E; Deiman B; Prüss H; Onur OA; Klein F; Fink GR; Di Cristanziano V; Warnke C
    Ann Neurol; 2022 Jan; 91(1):150-157. PubMed ID: 34724243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
    Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
    Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
    Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
    Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease.
    Wang ZB; Ma YH; Sun Y; Tan L; Wang HF; Yu JT;
    J Neuroinflammation; 2022 Dec; 19(1):316. PubMed ID: 36578067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue.
    Hosp JA; Reisert M; Dressing A; Götz V; Kellner E; Mast H; Arndt S; Waller CF; Wagner D; Rieg S; Urbach H; Weiller C; Schröter N; Rau A
    Nat Commun; 2024 May; 15(1):4256. PubMed ID: 38762609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.
    Hok-A-Hin YS; Del Campo M; Boiten WA; Stoops E; Vanhooren M; Lemstra AW; van der Flier WM; Teunissen CE
    J Neuroinflammation; 2023 May; 20(1):107. PubMed ID: 37147668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
    Apple AC; Oddi A; Peluso MJ; Asken BM; Henrich TJ; Kelly JD; Pleasure SJ; Deeks SG; Allen IE; Martin JN; Ndhlovu LC; Miller BL; Stephens ML; Hellmuth J
    Ann Clin Transl Neurol; 2022 Feb; 9(2):221-226. PubMed ID: 35043593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    Leng F; Zhan Z; Sun Y; Liu F; Edison P; Sun Y; Wang Z;
    J Alzheimers Dis; 2022; 88(1):117-126. PubMed ID: 35491791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification.
    Knapskog AB; Henjum K; Idland AV; Eldholm RS; Persson K; Saltvedt I; Watne LO; Engedal K; Nilsson LNG
    Sci Rep; 2020 Sep; 10(1):15886. PubMed ID: 32985583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in long-COVID.
    Julide T; Cigdem T; Baris T
    Ideggyogy Sz; 2024 May; 77(5-6):151-159. PubMed ID: 38829253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.
    Gispert JD; Suárez-Calvet M; Monté GC; Tucholka A; Falcon C; Rojas S; Rami L; Sánchez-Valle R; Lladó A; Kleinberger G; Haass C; Molinuevo JL
    Alzheimers Dement; 2016 Dec; 12(12):1259-1272. PubMed ID: 27423963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of brain lesions found using MRI imaging in patients with post-COVID with signs of cognitive decline.
    Kurakh AV; Ahii VI; Chopey IV; Hechko MM; Chubirko KI
    Wiad Lek; 2024; 77(3):383-386. PubMed ID: 38691776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.